BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21692933)

  • 1. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study.
    Fung J; Lai CL; Wong DK; Seto WK; Hung I; Yuen MF
    J Viral Hepat; 2011 Jul; 18(7):e200-5. PubMed ID: 21692933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
    Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
    Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B.
    Fung J; Lai CL; Seto WK; Wong DK; Yuen MF
    J Viral Hepat; 2011 Oct; 18(10):738-44. PubMed ID: 20659306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
    Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
    Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1762-9. PubMed ID: 23808759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir.
    Reijnders JG; Rijckborst V; Sonneveld MJ; Scherbeijn SM; Boucher CA; Hansen BE; Janssen HL
    J Hepatol; 2011 Mar; 54(3):449-54. PubMed ID: 21112655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].
    Shi JP; Fan JG; Lou GQ; Zhang L; Hu CB; Wu R; Xun YH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three years of continuous entecavir therapy in treatment-naïve chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety.
    Yuen MF; Seto WK; Fung J; Wong DK; Yuen JC; Lai CL
    Am J Gastroenterol; 2011 Jul; 106(7):1264-71. PubMed ID: 21364549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
    Leung NW; Lai CL; Chang TT; Guan R; Lee CM; Ng KY; Lim SG; Wu PC; Dent JC; Edmundson S; Condreay LD; Chien RN;
    Hepatology; 2001 Jun; 33(6):1527-32. PubMed ID: 11391543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
    Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
    Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.
    Fischler B; Nyström J; Björnsdottir T; Lindh G; Hultgren C
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):75-83. PubMed ID: 17592368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
    Kumar M; Chauhan R; Gupta N; Hissar S; Sakhuja P; Sarin SK
    Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
    Chien RN; Liaw YF; Atkins M
    Hepatology; 1999 Sep; 30(3):770-4. PubMed ID: 10462384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
    Chan HL; Wong GL; Choi PC; Chan AW; Chim AM; Yiu KK; Chan FK; Sung JJ; Wong VW
    J Viral Hepat; 2009 Jan; 16(1):36-44. PubMed ID: 18673426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers.
    Maimone S; Calvaruso V; Pleguezuelo M; Squadrito G; Amaddeo G; Jacobs M; Khanna P; Raimondo G; Dusheiko G
    J Viral Hepat; 2009 Nov; 16(11):769-74. PubMed ID: 19709363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.